An interventional study of Text Message Gamification and Remote Support in Medication Adherence, sponsored by Ascension Health. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-23.
Sponsored by Ascension Health · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 463 studies in Medication Adherence with a site in United States — 59 open to participants now, 74 under way, 1 of them phase 3. Medication Adherence · United States.
Among the 463 studies in Medication Adherence with a site in United States, this one is the 15th largest by planned enrollment of the 422 interventional ones that give a count, is one of 19 that started in 2026, is one of 368 with no phase, reaches primary completion later than 23 of the 73 other live ones, and was the 432nd registered.
943 studies on the registry are indexed under Medication Adherence; 162 are open to participants now.
Browse Medication Adherence studies →59 of the 463 studies in Medication Adherence with a site in United States are open now. Recruiting first, the newest first:
Duke University · Sites in United States
Ages 18+
Children's Hospital Medical Center, Cincinnati · Sites in United States
Ages 15–24
Children's Hospital Los Angeles · Sites in United States
Ages 10–17
Northwestern University · Sites in United States
Ages 60+
University of Oklahoma · Sites in United States
Ages 18+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 81 Medication Adherence studies recruiting now, 52 (64%) set no upper age limit and 21 (26%) stop at 75 or younger; 15 take children under 18; 12 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
463 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 20 · Phase 2 16 · Phase 3 12 · Phase 4 13
First in 1993; this study’s year is marked. 19 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 2,200 is above the median of 120 across 773 interventional studies indexed under Medication Adherence.
Median enrollment 96 across the 422 interventional studies, 140 across the 41 observational. Of the 359 that completed or were terminated, 138 (38%) have results posted.
This tab as a report to print or save as PDF → With an account.
28 of 463 have an industry lead sponsor. The 10 most frequent:
Ascension Health is the lead sponsor of 21 studies on the registry; 3 are open to participants now.
Ascension Health has 1 study filed under Medication Adherence — fewer than ten, so there is no comparison to draw.
39 of the studies in Medication Adherence with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06550804Phase 3University of Illinois at ChicagoTesting a Real-time Electronic Antiretroviral Adherence Monitoring Intervention | 2027-03 |
| NCT05997914University of Massachusetts, WorcesterStorytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation | 2026-11 |
| NCT04997499Tufts Medical CenterAdolescent Subcutaneous (SQ) Injection Video Validation | 2026-12 |
| NCT06865755San Diego State UniversityCollaborative Research: Multiscale Modeling and Intervention for Improving Long-Term Medication | 2026-12 |
| NCT07943663nucleusRx IncDevelopment of a Virtual Health Care Platform in Heart Failure Patients Transitioning From Hospital to Home | 2026-12-10 |
Add all 39 to your calendar (.ics) → With an account.
Among the 463 studies in Medication Adherence with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Statins have been demonstrated to significantly reduce the risk of cardiovascular disease, but adherence to these medications is suboptimal. Improving adherence can be challenging because it is multifactorial and behaviors often occur within the everyday lives of patients and are less addressable during a visit with a clinician. In this study, the investigators will conduct a randomized trial to evaluate a behaviorally-designed gamification intervention with remote nursing support to improve statin adherence.
Improving medication adherence can be challenging because behaviors occur within the everyday lives of patients. Therefore, intermittent visit-based adherence interventions or refill reminders have had limited impact. Remote Patient Monitoring (RPM) has been demonstrated in other settings to improve daily health behaviors when combined with automated outreach and a behavioral change strategy, such as gamification. These approaches have been demonstrated to be effective for other daily behaviors such as increasing physical activity levels among a wide range of patient populations including those at elevated risk for major cardiovascular events. MedTrack is a text message-based remote patient monitoring program with several key components: (I) medication check-ins with the ability to set the time(s) for daily medication reminders, (II) a gamification experience to drive behavior change, (III) ability to identify a support partner who receives weekly updates on the patient's game status; (IV) access to an RN team for clinical questions and care coordination, and (V) patients' providers can see real-time progress within an electronic health record (EHR) integrated application.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants in the usual care arm will have consented for participation and will be informed they are on a waiting list for approximately 6-12 months. During that time they will receive no additional interventions beyond usual care and not be be invited again to enroll in the MedTrack program.
Participants in the intervention arm will have consented for participation in the MedTrack program and will receive the text message intervention and remote support within 1-2 weeks of enrolling.
Behavioral: Text Message Gamification and Remote Support
Participants in the intervention arm consists of several components: (I) medication check-ins with the ability to set the time(s) for daily medication reminders, (II) a gamification experience to drive behavior change, (III) ability to identify a support partner who receives weekly updates on the patient's game status; (IV) access to an RN team for clinical questions and care coordination, and (V) patients' providers can see real-time progress within an electronic health record (EHR) integrated application.
Statin adherence, population average
Statin adherence, measured using the proportion of days covered (PDC), during the 6-month intervention period
Time frame: 6-months after enrollment
Statin adherence, proportion of population with PDC>=80%
Proportion of patients with statin PDC adherence greater than or equal to 80% during the 6-month intervention period
Time frame: 6-months after enrollment
Plan to share: No — The study has patient information that the investigators are not approved to share.
No publications or documents are linked to this record.
Started Apr 2026 (actual). Primary completion is estimated for Mar 2027, 11 months after the start.
Of 447 interventional studies with no phase under Medication Adherence, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 41. This study's planned 11 months is below that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ascension Health